PRR-signaling pathways: Learning from microbial tactics

Seminars in Immunology

Volumn 27, Issue 2, 2015, Pages 75-84

  Sellge, Gernot ^a   Kufer, Thomas A ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Actin; Inflammation; Kinase; NLR; Signaling; T3SS; TLR

Indexed keywords

GUANOSINE TRIPHOSPHATASE; INFLAMMASOME; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR;

CAMPYLOBACTER JEJUNI; CHEMICAL MODIFICATION; COMMENSAL; COMPLEX FORMATION; CROHN DISEASE; GENETIC RISK; HOST CELL; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LOSS OF FUNCTION MUTATION; MAMMAL CELL; MICROORGANISM; NEISSERIA GONORRHOEAE; PATHOGENESIS; QUORUM SENSING; RECOGNITION; REVIEW; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SIGNAL TRANSDUCTION; VIBRIO CHOLERAE; ANIMAL; AUTOPHAGY; BACTERIAL INFECTION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; CELL MEMBRANE; CLASSIFICATION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; SYMBIOSIS;

ANIMALS; AUTOPHAGY; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL MEMBRANE; HUMANS; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; SYMBIOSIS;

EID: 84931567058     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.03.009     Document Type: Review

References (127)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Wagner H. Innate immunity's path to the Nobel Prize 2011 and beyond. Eur. J. Immunol. 2012, 42:1089-1092.
3. Alto N.M., Orth K. Subversion of cell signaling by pathogens. Cold Spring Harbor Perspect. Biol. 2012, 4:a006114.
4. Baxt L.A., Garza-Mayers A.C., Goldberg M.B. Bacterial subversion of host innate immune pathways. Science 2013, 340:697-701.
5. Hilbi H., Haas A. Secretive bacterial pathogens and the secretory pathway. Traffic 2012, 13:1187-1197.
6. Tauber A.I. Metchnikoff and the phagocytosis theory. Nat. Rev. Mol. Cell Biol. 2003, 4:897-901.
7. Gomes L.C., Dikic I. Autophagy in antimicrobial immunity. Mol. Cell. 2014, 54:224-233.
8. Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011, 333:228-233.
9. Mostowy S., Sancho-Shimizu V., Hamon M.A., Simeone R., Brosch R., Johansen T., et al. p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways. J. Biol. Chem. 2011, 286:26987-26995.
10. Dupont N., Lacas-Gervais S., Bertout J., Paz I., Freche B., Van Nhieu G.T., et al. Shigella phagocytic vacuolar membrane remnants participate in the cellular response to pathogen invasion and are regulated by autophagy. Cell Host Microbe 2009, 6:137-149.
11. Choy A., Dancourt J., Mugo B., O'Connor T.J., Isberg R.R., Melia T.J., et al. The Legionella effector RavZ inhibits host autophagy through irreversible Atg8 deconjugation. Science 2012, 338:1072-1076.
12. Burnaevskiy N., Fox T.G., Plymire D.A., Ertelt J.M., Weigele B.A., Selyunin A.S., et al. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 2013, 496:106-109.
13. Erridge C., Bennett-Guerrero E., Poxton I.R. Structure and function of lipopolysaccharides. Microbes Infect. 2002, 4:837-851.
14. Andersen-Nissen E., Smith K.D., Strobe K.L., Barrett S.L., Cookson B.T., Logan S.M., et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9247-9252.
15. Galkin V.E., Yu X., Bielnicki J., Heuser J., Ewing C.P., Guerry P., et al. Divergence of quaternary structures among bacterial flagellar filaments. Science 2008, 320:382-385.
16. Miao E.A., Andersen-Nissen E., Warren S.E., Aderem A. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol. 2007, 29:275-288.
17. Chaput C., Ecobichon C., Cayet N., Girardin S.E., Werts C., Guadagnini S., et al. Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2006, 2:e97.
18. Boneca I.G., Dussurget O., Cabanes D., Nahori M.A., Sousa S., Lecuit M., et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:997-1002.
19. Thay B., Damm A., Kufer T.A., Wai S.N., Oscarsson J. Aggregatibacter actinomycetemcomitans outer membrane vesicles are internalized in human host cells and trigger NOD1- and NOD2-dependent NF-kappaB activation. Infect. Immun. 2014, 82:4034-4046.
20. Kaparakis M., Turnbull L., Carneiro L., Firth S., Coleman H.A., Parkington H.C., et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell. Microbiol. 2010, 12:372-385.
21. Bielig H., Rompikuntal P.K., Dongre M., Zurek B., Lindmark B., Ramstedt M., et al. NOD-like receptor activation by outer membrane vesicles from Vibrio cholerae non-O1 non-O139 strains is modulated by the quorum-sensing regulator HapR. Infect. Immun. 2011, 79:1418-1427.
22. Collins B.S. Gram-negative outer membrane vesicles in vaccine development. Discov. Med. 2011, 12:7-15.
23. Magalhaes J.G., Fritz J.H., Le Bourhis L., Sellge G., Travassos L.H., Selvanantham T., et al. Nod2-dependent Th2 polarization of antigen-specific immunity. J. Immunol. 2008, 181:7925-7935.
24. Fritz J.H., Le Bourhis L., Sellge G., Magalhaes J.G., Fsihi H., Kufer T.A., et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007, 26:445-459.
25. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430:257-263.
26. Pearson J.S., Riedmaier P., Marches O., Frankel G., Hartland E.L. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol. Microbiol. 2011, 80:219-230.
27. Yen H., Ooka T., Iguchi A., Hayashi T., Sugimoto N., Tobe T. NleC, a type III secretion protease, compromises NF-kappaB activation by targeting p65/RelA. PLoS Pathog. 2010, 6. e1001231.
28. Zinngrebe J., Montinaro A., Peltzer N., Walczak H. Ubiquitin in the immune system. EMBO Rep. 2014, 15:28-45.
29. Emmerich C.H., Schmukle A.C., Walczak H. The emerging role of linear ubiquitination in cell signaling. Sci. Signal. 2011, 4:re5.
30. Rodgers M.A., Bowman J.W., Fujita H., Orazio N., Shi M., Liang Q., et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J. Exp. Med. 2014, 211:1333-1347.
31. Huibregtse J., Rohde J.R. Hell's BELs: bacterial E3 ligases that exploit the eukaryotic ubiquitin machinery. PLoS Pathog. 2014, 10:e1004255.
32. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 2010, 12(66-73):61-69.
33. Taieb F., Nougayrede J.P., Oswald E. Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin-dependent degradation pathway of host cells. Toxins 2011, 3:356-368.
34. Zhou Y., Zhu Y. Diversity of bacterial manipulation of the host ubiquitin pathways. Cell. Microbiol. 2015, 17:26-34.
35. Philpott D.J., Sorbara M.T., Robertson S.J., Croitoru K., Girardin S.E. NOD proteins: regulators of inflammation in health and disease. Nat. Rev. Immunol. 2014, 14:9-23.
36. Andree M., Seeger J.M., Schull S., Coutelle O., Wagner-Stippich D., Wiegmann K., et al. BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J. 2014, 33:2171-2187.
37. Bielig H., Lautz K., Braun P.R., Menning M., Machuy N., Brugmann C., et al. The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling. PLoS Pathog. 2014, 10:e1004351.
38. Damgaard R.B., Gyrd-Hansen M. Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity. Discov. Med. 2011, 11:221-231.
39. Krieg A., Correa R.G., Garrison J.B., Le Negrate G., Welsh K., Huang Z., et al. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14524-14529.
40. Bertrand M.J., Doiron K., Labbe K., Korneluk R.G., Barker P.A., Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 2009, 30:789-801.
41. Pedersen J., LaCasse E.C., Seidelin J.B., Coskun M., Nielsen O.H. Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation. Trends Mol. Med. 2014, 20:652-665.
42. Frank C.G., Reguerio V., Rother M., Moranta D., Maeurer A.P., Garmendia J., et al. Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation. Cell. Microbiol. 2013, 15:1212-1233.
43. Regueiro V., Moranta D., Frank C.G., Larrarte E., Margareto J., March C., et al. Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner. Cell. Microbiol. 2011, 13:135-153.
44. Meinzer U., Barreau F., Esmiol-Welterlin S., Jung C., Villard C., Leger T., et al. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 2012, 11:337-351.
45. Mittal R., Peak-Chew S.Y., McMahon H.T. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18574-18579.
46. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006, 312:1211-1214.
47. Paquette N., Conlon J., Sweet C., Rus F., Wilson L., Pereira A., et al. Serine/threonine acetylation of TGFbeta-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12710-12715.
48. Li H., Xu H., Zhou Y., Zhang J., Long C., Li S., et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
49. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 2007, 8:47-56.
50. Harouz H., Rachez C., Meijer B.M., Marteyn B., Donnadieu F., Cammas F., et al. Shigella flexneri targets the HP1gamma subcode through the phosphothreonine lyase OspF. EMBO J. 2014, 33:2606-2622.
51. Lebreton A., Lakisic G., Job V., Fritsch L., Tham T.N., Camejo A., et al. A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science 2011, 331:1319-1321.
52. Eskandarian H.A., Impens F., Nahori M.A., Soubigou G., Coppee J.Y., Cossart P., et al. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 2013, 341:1238858.
53. Rana R.R., Zhang M., Spear A.M., Atkins H.S., Byrne B. Bacterial TIR-containing proteins and host innate immune system evasion. Med. Microbiol. Immunol. 2013, 202:1-10.
54. Cirl C., Wieser A., Yadav M., Duerr S., Schubert S., Fischer H., et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 2008, 14:399-406.
55. Newman R.M., Salunkhe P., Godzik A., Reed J.C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 2006, 74:594-601.
56. Sengupta D., Koblansky A., Gaines J., Brown T., West A.P., Zhang D., et al. Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. J. Immunol. 2010, 184:956-964.
57. Smith K., Humphreys D., Hume P.J., Koronakis V. Enteropathogenic Escherichia coli recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host Microbe 2010, 7:13-24.
58. Yan D., Wang X., Luo L., Cao X., Ge B. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs. Nat. Immunol. 2012, 13:1063-1071.
59. Cunha L.D., Zamboni D.S. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria. Front. Cell. Infect. Microbiol. 2013, 3:76.
60. Brodsky I.E., Palm N.W., Sadanand S., Ryndak M.B., Sutterwala F.S., Flavell R.A., et al. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 2010, 7:376-387.
61. Galle M., Schotte P., Haegman M., Wullaert A., Yang H.J., Jin S., et al. The Pseudomonas aeruginosa Type III secretion system plays a dual role in the regulation of caspase-1 mediated IL-1beta maturation. J. Cell. Mol. Med. 2008, 12:1767-1776.
62. Sutterwala F.S., Mijares L.A., Li L., Ogura Y., Kazmierczak B.I., Flavell R.A. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 2007, 204:3235-3245.
63. Master S.S., Rampini S.K., Davis A.S., Keller C., Ehlers S., Springer B., et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 2008, 3:224-232.
64. LaRock C.N., Cookson B.T. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe 2012, 12:799-805.
65. Kobayashi T., Ogawa M., Sanada T., Mimuro H., Kim M., Ashida H., et al. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe 2013, 13:570-583.
66. Aktories K. Bacterial protein toxins that modify host regulatory GTPases. Nat. Rev. Microbiol. 2011, 9:487-498.
67. Friebel A., Ilchmann H., Aepfelbacher M., Ehrbar K., Machleidt W., Hardt W.D. SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J. Biol. Chem. 2001, 276:34035-34040.
68. Rudolph M.G., Weise C., Mirold S., Hillenbrand B., Bader B., Wittinghofer A., et al. Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases. J. Biol. Chem. 1999, 274:30501-30509.
69. Schlumberger M.C., Hardt W.D. Triggered phagocytosis by Salmonella: bacterial molecular mimicry of RhoGTPase activation/deactivation. Curr. Top. Microbiol. Immunol. 2005, 291:29-42.
70. Black D.S., Bliska J.B. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 2000, 37:515-527.
71. Von Pawel-Rammingen U., Telepnev M.V., Schmidt G., Aktories K., Wolf-Watz H., Rosqvist R. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol. Microbiol. 2000, 36:737-748.
72. Engel J., Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 2009, 12:61-66.
73. Aktories K., Just I. Clostridial Rho-inhibiting protein toxins. Curr. Top. Microbiol. Immunol. 2005, 291:113-145.
74. Shao F., Merritt P.M., Bao Z., Innes R.W., Dixon J.E. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 2002, 109:575-588.
75. Dangl J.L., Horvath D.M., Staskawicz B.J. Pivoting the plant immune system from dissection to deployment. Science 2013, 341:746-751.
76. Qi D., Innes R.W. Recent advances in plant NLR structure, function, localization, and signaling. Front. Immunol. 2013, 4:348.
77. Ting J.P., Kastner D.L., Hoffman H.M. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 2006, 6:183-195.
78. Xu H., Yang J., Gao W., Li L., Li P., Zhang L., et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 2014, 513:237-241.
79. Kufer T.A., Kremmer E., Adam A.C., Philpott D.J., Sansonetti P.J. The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell. Microbiol. 2008, 10:477-486.
80. Fukazawa A., Alonso C., Kurachi K., Gupta S., Lesser C.F., McCormick B.A., et al. GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog. 2008, 4:e1000228.
81. Keestra A.M., Winter M.G., Auburger J.J., Frassle S.P., Xavier M.N., Winter S.E., et al. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 2013, 496:233-237.
82. Keestra A.M., Winter M.G., Klein-Douwel D., Xavier M.N., Winter S.E., Kim A., et al. A Salmonella virulence factor activates the NOD1/NOD2 signaling pathway. mBio 2011, 2011.
83. Man S.M., Ekpenyong A., Tourlomousis P., Achouri S., Cammarota E., Hughes K., et al. Actin polymerization as a key innate immune effector mechanism to control Salmonella infection. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:17588-17593.
84. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3076-3080.
85. Suzuki S., Franchi L., He Y., Munoz-Planillo R., Mimuro H., Suzuki T., et al. Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcdelta. PLoS Pathog. 2014, 10:e1003926.
86. Yang J., Zhao Y., Shi J., Shao F. Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:14408-14413.
87. Zheng Y., Lilo S., Brodsky I.E., Zhang Y., Medzhitov R., Marcu K.B., et al. A Yersinia effector with enhanced inhibitory activity on the NF-kappaB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog. 2011, 7:e1002026.
88. Robinson N., McComb S., Mulligan R., Dudani R., Krishnan L., Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 2012, 13:954-962.
89. O'Connell R.M., Saha S.K., Vaidya S.A., Bruhn K.W., Miranda G.A., Zarnegar B., et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 2004, 200:437-445.
90. Auerbuch V., Brockstedt D.G., Meyer-Morse N., O'Riordan M., Portnoy D.A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 2004, 200:527-533.
91. Eshleman E.M., Lenz L.L. Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity. Front. Immunol. 2014, 5:431.
92. Fukata M., Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol. 2013, 6:451-463.
93. Kamada N., Nunez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014, 146:1477-1488.
94. Rosenstiel P. Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine. Curr. Opin. Gastroenterol. 2013, 29:125-132.
95. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., Gaynor E.C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2:204.
96. Stecher B., Hardt W.D. The role of microbiota in infectious disease. Trends Microbiol. 2008, 16:107-114.
97. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
98. Vaishnava S., Yamamoto M., Severson K.M., Ruhn K.A., Yu X., Koren O., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
99. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
100. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
101. Couturier-Maillard A., Secher T., Rehman A., Normand S., De Arcangelis A., Haesler R., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Investig. 2013, 123:700-711.
102. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
103. Rehman A., Sina C., Gavrilova O., Hasler R., Ott S., Baines J.F., et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011, 60:1354-1362.
104. Fanning S., Hall L.J., van Sinderen D. Bifidobacterium breve UCC2003 surface exopolysaccharide production is a beneficial trait mediating commensal-host interaction through immune modulation and pathogen protection. Gut Microbes 2012, 3:420-425.
105. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000, 289:1560-1563.
106. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 2004, 5:104-112.
107. Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppee J.Y., et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 2006, 176:1228-1237.
108. Neish A.S., Jones R.M. Redox signaling mediates symbiosis between the gut microbiota and the intestine. Gut Microbes 2014, 5:250-253.
109. Kumar A., Wu H., Collier-Hyams L.S., Hansen J.M., Li T., Yamoah K., et al. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 2007, 26:4457-4466.
110. Kumar A., Wu H., Collier-Hyams L.S., Kwon Y.M., Hanson J.M., Neish A.S. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J. Immunol. 2009, 182:538-546.
111. Kabat A.M., Srinivasan N., Maloy K.J. Modulation of immune development and function by intestinal microbiota. Trends Immunol. 2014.
112. Bouskra D., Brezillon C., Berard M., Werts C., Varona R., Boneca I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
113. Tezuka H., Abe Y., Iwata M., Takeuchi H., Ishikawa H., Matsushita M., et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 2007, 448:929-933.
114. Uematsu S., Fujimoto K., Jang M.H., Yang B.G., Jung Y.J., Nishiyama M., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008, 9:769-776.
115. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
116. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
117. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
118. Yang Y., Torchinsky M.B., Gobert M., Xiong H., Xu M., Linehan J.L., et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 2014, 510:152-156.
119. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
120. Hall J.A., Bouladoux N., Sun C.M., Wohlfert E.A., Blank R.B., Zhu Q., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
121. Geuking M.B., Cahenzli J., Lawson M.A., Ng D.C., Slack E., Hapfelmeier S., et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011, 34:794-806.
122. Dasgupta S., Erturk-Hasdemir D., Ochoa-Reparaz J., Reinecker H.C., Kasper D.L. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 2014, 15:413-423.
123. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
124. Wang Y., Telesford K.M., Ochoa-Reparaz J., Haque-Begum S., Christy M., Kasper E.J., et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat. Commun. 2014, 5:4432.
125. Sansonetti P.J. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol. 2011, 4:8-14.
126. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 1989, 54(Pt 1):1-13.
127. Maekawa T., Kufer T.A., Schulze-Lefert P. NLR functions in plant and animal immune systems: so far and yet so close. Nat. Immunol. 2011, 12:817-826.